Login / Signup

The WHOQOL-BREF: a modern psychometric evaluation of its internal construct validity in people with multiple sclerosis.

I M PomeroyAlan TennantR J Millsnull nullCarolyn Anne Young
Published in: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation (2020)
The validation of multiple conceptual frameworks validates the WHOQOL-BREF as a powerful and flexible end-point for use in clinical trials and in testing conceptual models of factors influencing QoL in MS.
Keyphrases
  • multiple sclerosis
  • clinical trial
  • white matter
  • mass spectrometry
  • ms ms
  • randomized controlled trial
  • phase iii
  • double blind